Cargando…
Naive CD4 T-cell activation identifies MS patients having rapid transition to progressive MS
OBJECTIVE: Our objective was to determine whether altered naive CD4 T-cell biology contributes to development of disease progression in secondary progressive multiple sclerosis (SPMS). METHODS: We compared the naive CD4 T-cell gene expression profiles of 19 patients with SPMS and 14 healthy controls...
Autores principales: | Zastepa, Evelyn, Fitz-Gerald, Leslie, Hallett, Michael, Antel, Jack, Bar-Or, Amit, Baranzini, Sergio, Lapierre, Yves, Haegert, David G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945666/ https://www.ncbi.nlm.nih.gov/pubmed/24453076 http://dx.doi.org/10.1212/WNL.0000000000000146 |
Ejemplares similares
-
Dimethyl fumarate–induced lymphopenia in MS due to differential T-cell subset apoptosis
por: Ghadiri, Mahtab, et al.
Publicado: (2017) -
MerTK-mediated regulation of myelin phagocytosis by macrophages generated from patients with MS
por: Healy, Luke M., et al.
Publicado: (2017) -
Mendelian randomization study shows no causal effects of serum urate levels on the risk of MS
por: Harroud, Adil, et al.
Publicado: (2020) -
COVID-19 and MS disease-modifying therapies
por: Berger, Joseph R., et al.
Publicado: (2020) -
Mononuclear cell transcriptome changes associated with dimethyl fumarate in MS
por: Gafson, Arie R., et al.
Publicado: (2018)